ClinicalTrials.Veeva

Menu

Performance and Safety of the Lipo-transfer Cannulas in Patients Underlying Lipofilling Treatment

A

Aesthetic Group

Status

Completed

Conditions

Lipodystrophy
Deformities

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT06089759
LIPOTRANSFER

Details and patient eligibility

About

The purpose of this post-market clinical follow up study is to assess the safety and performance of Aesthetic Group cannulas. The study will evaluate the outcome of the Aesthetic Group cannulas range over a period of 1 month after intervention.

Enrollment

108 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient age ≥ 18 years at intervention
  • Patient who will undergo a lipofilling treatment with at least one cannula of Aesthetic Group
  • Patient informed of his/her participation and willing to participate in the study.
  • Patient able to read, write and understand French.

Exclusion criteria

  • Patient deprived of freedom, under guardianship/curatorship or placed under judicial protection
  • Patient unable to follow study procedures
  • Patient with hematologic abnormalities, prior radiotherapy or chemotherapy
  • Chronic use of medicines or drugs
  • Patient with diabetes mellitus
  • Patient with connective tissue diseases, any type of fat tissue disorder (lipodystrophy)
  • Patient with bleeding disorders; immune deficits; heart, liver, and kidney insufficiency
  • Patient with allergies to local anaesthetics
  • Patient with pacemaker and serious heart rhythm disorders
  • Pregnant and breastfeeding women

Trial contacts and locations

3

Loading...

Central trial contact

Valérie BOQUET

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems